OPG can reserve bone loss in models of sex-steroid insufficiency and glucocorticoid-induced osteoporosis, rheumatoid arthritis, multiple myeloma, and metastatic bone disease (12). The gene discussed is TNFRSF11B; the disease is AL amyloidosis.